Breaking News Instant updates and real-time market news.

AMD

AMD

$92.76 /

+1.24 (+1.35%)

, INTC

Intel

$56.66 /

-5.81 (-9.30%)

06:22
01/25/21
01/25
06:22
01/25/21
06:22

Citi opens 'positive catalyst watch' on AMD but keeps $13 price target

Citi analyst Christopher Danely expects continued PC end market strength and Intel's (INTC) data center weakness to provide upside to AMD's (AMD) Q4 earnings and guidance. As such, he opened a "positive catalyst watch" on AMD shares on expectations the stock to trade up after the earnings call. However, he maintains Sell rating on the stock with a $13 price target. Danely continues to expect the pricing competition between Intel and AMD to intensity later this year, "which will likely be detrimental for both."

AMD

AMD

$92.76 /

+1.24 (+1.35%)

INTC

Intel

$56.66 /

-5.81 (-9.30%)

  • 26

    Jan

  • 22

    Apr

AMD AMD
$92.76 /

+1.24 (+1.35%)

01/22/21 Truist
Intel price target raised to $64 from $60 at Truist
01/14/21 Cowen
AMD price target raised to $110 from $100 at Cowen
01/14/21 BMO Capital
Intel upgraded to Outperform from Market Perform at BMO Capital
01/14/21 BMO Capital
AMD downgraded to Underperform from Market Perform at BMO Capital
INTC Intel
$56.66 /

-5.81 (-9.30%)

01/22/21 Jefferies
Intel has 'no easy or quick fix,' says Jefferies
01/22/21 Morgan Stanley
Intel price target raised to $72 after 'very strong quarter' at Morgan Stanley
01/22/21 Roth Capital
Intel price target raised to $60 from $50 at Roth Capital

TODAY'S FREE FLY STORIES

Earnings
Eastman Kodak reports Q1 revenue $209M vs $210 last year » 16:21
05/12/21
05/12
16:21
05/12/21
16:21
KODK

Eastman Kodak

$6.80 /

-0.39 (-5.42%)

Reports Q1 net income $6M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KODK Eastman Kodak
$6.80 /

-0.39 (-5.42%)

KODK Eastman Kodak
$6.80 /

-0.39 (-5.42%)

KODK Eastman Kodak
$6.80 /

-0.39 (-5.42%)

KODK Eastman Kodak
$6.80 /

-0.39 (-5.42%)

Earnings
Evoke Pharma reports Q1 EPS (8c), consensus (6c) » 16:21
05/12/21
05/12
16:21
05/12/21
16:21
EVOK

Evoke Pharma

$1.53 /

-0.02 (-1.29%)

Reports Q1 revenue $90K,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVOK Evoke Pharma
$1.53 /

-0.02 (-1.29%)

EVOK Evoke Pharma
$1.53 /

-0.02 (-1.29%)

06/22/20 H.C. Wainwright
Evoke Pharma upgraded to Buy from Neutral at H.C. Wainwright
  • 14
    Jan
Downgrade
Ferro downgraded to Neutral from Buy at Seaport Global » 16:21
05/12/21
05/12
16:21
05/12/21
16:21
FOE

Ferro

/

+

Seaport Global analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOE Ferro
/

+

FOE Ferro
/

+

08:25 Today Gabelli
Ferro downgraded to Sell from Buy at Gabelli
06:48 Today Deutsche Bank
Ferro downgraded on 'fair but not full' buyout price at Deutsche Bank
06:00 Today JPMorgan
Ferro downgraded to Underweight from Neutral at JPMorgan
05/11/21 Deutsche Bank
Ferro downgraded to Hold from Buy at Deutsche Bank
FOE Ferro
/

+

FOE Ferro
/

+

Hot Stocks
AllianceBernstein reports preliminary AUM $724B as of April 30 » 16:21
05/12/21
05/12
16:21
05/12/21
16:21
AB

AllianceBernstein

$41.72 /

-1.72 (-3.96%)

Up from $697 B at the end…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AB AllianceBernstein
$41.72 /

-1.72 (-3.96%)

AB AllianceBernstein
$41.72 /

-1.72 (-3.96%)

05/11/21 Truist
Equitable Holdings price target raised to $43 from $37 at Truist
04/09/21 BofA
BofA downgrades AllianceBernstein to Neutral, sees weaker near-term performance
04/09/21 BofA
AllianceBernstein downgraded to Neutral from Buy at BofA
04/05/21 Keefe Bruyette
AllianceBernstein downgraded to Market Perform from Outperform at Keefe Bruyette
AB AllianceBernstein
$41.72 /

-1.72 (-3.96%)

AB AllianceBernstein
$41.72 /

-1.72 (-3.96%)

Initiation
Microsoft initiated with a Buy at Rosenblatt » 16:21
05/12/21
05/12
16:21
05/12/21
16:21
MSFT

Microsoft

$239.05 /

-7.18 (-2.92%)

Rosenblatt analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$239.05 /

-7.18 (-2.92%)

MSFT Microsoft
$239.05 /

-7.18 (-2.92%)

05/11/21 Morgan Stanley
Morgan Stanley downgrades Nuance, doesn't see Microsoft deal being beat
05/07/21 LightShed Partners
LightShed Partners starts Roblox at Buy with $85 price target
04/28/21 Wedbush
Microsoft price target raised to $310 from $300 at Wedbush
04/28/21 Oppenheimer
Microsoft reports 'impressive' Q3 as cloud momentum continues, says Oppenheimer
MSFT Microsoft
$239.05 /

-7.18 (-2.92%)

MSFT Microsoft
$239.05 /

-7.18 (-2.92%)

MSFT Microsoft
$239.05 /

-7.18 (-2.92%)

MSFT Microsoft
$239.05 /

-7.18 (-2.92%)

Hot Stocks
Salesforce urges shareholders to reject 'mini-tender' offer by Tutanota » 16:20
05/12/21
05/12
16:20
05/12/21
16:20
CRM

Salesforce

$210.53 /

-5.1 (-2.37%)

Salesforce announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$210.53 /

-5.1 (-2.37%)

CRM Salesforce
$210.53 /

-5.1 (-2.37%)

05/03/21 BofA
BofA adds Disney and Avalara, removes Comcast and Netflix from U.S. 1 List
04/22/21 Wolfe Research
Salesforce initiated with an Outperform at Wolfe Research
04/05/21 Credit Suisse
Salesforce assumed with an Outperform at Credit Suisse
03/24/21 Nord/LB
Salesforce downgraded to Hold from Buy at Nord/LB
CRM Salesforce
$210.53 /

-5.1 (-2.37%)

CRM Salesforce
$210.53 /

-5.1 (-2.37%)

CRM Salesforce
$210.53 /

-5.1 (-2.37%)

CRM Salesforce
$210.53 /

-5.1 (-2.37%)

Options
Closing CBOE SPX and VIX Index summary for May 12th » 16:20
05/12/21
05/12
16:20
05/12/21
16:20
VIX

Volatility Index S&P 500 Options

/

+

The CBOE Volatility Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VIX Volatility Index S&P 500 Options
/

+

Earnings
Fuel Tech reports Q1 EPS 1c, consensus 6c » 16:19
05/12/21
05/12
16:19
05/12/21
16:19
FTEK

Fuel Tech

$1.94 /

+0.025 (+1.31%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FTEK Fuel Tech
$1.94 /

+0.025 (+1.31%)

FTEK Fuel Tech
$1.94 /

+0.025 (+1.31%)

Hot Stocks
CPSI acquires TruCode, terms not disclosed » 16:19
05/12/21
05/12
16:19
05/12/21
16:19
CPSI

Computer Programs

$29.73 /

-0.51 (-1.69%)

CPSI announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CPSI Computer Programs
$29.73 /

-0.51 (-1.69%)

CPSI Computer Programs
$29.73 /

-0.51 (-1.69%)

06:52 Today Deutsche Bank
Computer Programs price target lowered to $28 from $33 at Deutsche Bank
02/16/21 Piper Sandler
Computer Programs price target raised to $30 from $27 at Piper Sandler
01/08/21 SVB Leerink
Computer Programs assumed with an Outperform at SVB Leerink
09/10/20 KeyBanc
Computer Programs upgraded to Sector Weight from Underweight at KeyBanc
CPSI Computer Programs
$29.73 /

-0.51 (-1.69%)

CPSI Computer Programs
$29.73 /

-0.51 (-1.69%)

Earnings
PLBY Group reports Q1 revenue $42.7M, consensus $38.47M » 16:19
05/12/21
05/12
16:19
05/12/21
16:19
PLBY

PLBY Group

$41.59 /

-4.41 (-9.59%)

Reports Q1 adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLBY PLBY Group
$41.59 /

-4.41 (-9.59%)

PLBY PLBY Group
$41.59 /

-4.41 (-9.59%)

04/07/21 Roth Capital
PLBY Group price target raised to $35 from $26 at Roth Capital
04/06/21 Canaccord
Canaccord sees Nifty Gateway partnership as initial step in PLBY's NFT strategy
03/31/21 Canaccord
PLBY Group initiated with a Buy at Canaccord
03/24/21 Craig-Hallum
PLBY Group price target raised to $35 from $25 at Craig-Hallum
PLBY PLBY Group
$41.59 /

-4.41 (-9.59%)

PLBY PLBY Group
$41.59 /

-4.41 (-9.59%)

PLBY PLBY Group
$41.59 /

-4.41 (-9.59%)

PLBY PLBY Group
$41.59 /

-4.41 (-9.59%)

Earnings
cbdMD sees Q3 revenue $15.5M-$16.25M, consensus $13.53M  16:19
05/12/21
05/12
16:19
05/12/21
16:19
YCBD

cbdMD

$3.48 /

+0.05 (+1.46%)

 
ShowHide Related Items >><<
YCBD cbdMD
$3.48 /

+0.05 (+1.46%)

YCBD cbdMD
$3.48 /

+0.05 (+1.46%)

YCBD cbdMD
$3.48 /

+0.05 (+1.46%)

YCBD cbdMD
$3.48 /

+0.05 (+1.46%)

Earnings
Trean Insurance reports Q1 EPS 16c, consensus 19c » 16:19
05/12/21
05/12
16:19
05/12/21
16:19
TIG

Trean Insurance

$16.75 /

-0.535 (-3.10%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TIG Trean Insurance
$16.75 /

-0.535 (-3.10%)

01/04/21 JPMorgan
Trean Insurance price target lowered to $17 from $18 at JPMorgan
08/14/20 William Blair
Trean Insurance initiated with an Outperform at William Blair
08/10/20
Fly Intel: Top five analyst initiations
08/10/20 JPMorgan
Trean Insurance initiated with a Neutral at JPMorgan
TIG Trean Insurance
$16.75 /

-0.535 (-3.10%)

  • 16
    Jul
Earnings
Viracta Therapeutics reports Q1 EPS ($5.22), consensus (21c) » 16:19
05/12/21
05/12
16:19
05/12/21
16:19
VIRX

Viracta Therapeutics

$9.20 /

+0.38 (+4.31%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VIRX Viracta Therapeutics
$9.20 /

+0.38 (+4.31%)

VIRX Viracta Therapeutics
$9.20 /

+0.38 (+4.31%)

05/03/21 H.C. Wainwright
Viracta Therapeutics initiated with a Buy at H.C. Wainwright
04/26/21 SVB Leerink
SVB Leerink bullish on Viracta Therapeutics, initiates with an Outperform
04/26/21 SVB Leerink
Viracta Therapeutics initiated with an Outperform at SVB Leerink
03/25/21
Fly Intel: Top five analyst initiations
Hot Stocks
Cal-Maine Foods acquires remaining interest in Red River Valley Egg Farm » 16:18
05/12/21
05/12
16:18
05/12/21
16:18
CALM

Cal-Maine Foods

$36.90 /

-0.905 (-2.39%)

Cal-Maine Foods announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CALM Cal-Maine Foods
$36.90 /

-0.905 (-2.39%)

CALM Cal-Maine Foods
$36.90 /

-0.905 (-2.39%)

12/30/20 Stephens
Cal-Maine Foods price target lowered to $47 from $55 at Stephens
10/28/20
Fly Intel: Top five analyst initiations
10/28/20 BofA
Cal-Maine Foods initiated with a Buy at BofA
10/28/20 BofA
Cal-Maine Foods initiated with a Buy at BofA
CALM Cal-Maine Foods
$36.90 /

-0.905 (-2.39%)

  • 20
    Aug
CALM Cal-Maine Foods
$36.90 /

-0.905 (-2.39%)

CALM Cal-Maine Foods
$36.90 /

-0.905 (-2.39%)

Earnings
AppLovin sees FY21 revenue $2.65B-$2.7B, or 83% growth » 16:18
05/12/21
05/12
16:18
05/12/21
16:18
APP

AppLovin

$52.11 /

-1.2 (-2.25%)

Sees FY21 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APP AppLovin
$52.11 /

-1.2 (-2.25%)

05/10/21
Fly Intel: Top five analyst initiations
05/10/21 Stifel
AppLovin initiated with a Hold at Stifel
05/10/21 UBS
AppLovin initiated with a Buy at UBS
05/10/21 Truist
AppLovin initiated with a Buy at Truist
APP AppLovin
$52.11 /

-1.2 (-2.25%)

  • 15
    Apr
APP AppLovin
$52.11 /

-1.2 (-2.25%)

APP AppLovin
$52.11 /

-1.2 (-2.25%)

Hot Stocks
Manning & Napier reports preliminary AUM $21.9B as of April 30 » 16:18
05/12/21
05/12
16:18
05/12/21
16:18
MN

Manning & Napier

$7.22 /

+ (+0.00%)

Compared with $21.1B at…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MN Manning & Napier
$7.22 /

+ (+0.00%)

Hot Stocks
Qiagen receives FDA emergency use authorization for QIAreach test » 16:18
05/12/21
05/12
16:18
05/12/21
16:18
QGEN

Qiagen

$46.26 /

-0.125 (-0.27%)

Qiagen announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QGEN Qiagen
$46.26 /

-0.125 (-0.27%)

QGEN Qiagen
$46.26 /

-0.125 (-0.27%)

02/19/21 Berenberg
Qiagen price target raised to EUR 56 from EUR 52 at Berenberg
02/09/21 William Blair
Quidel, Qiagen merger would not make sense, says William Blair
02/09/21 Wells Fargo
Qiagen shares should be sold on latest merger talk, says Wells Fargo
02/09/21 Citi
Merger with Qiagen would benefit Quidel, says Citi
QGEN Qiagen
$46.26 /

-0.125 (-0.27%)

QGEN Qiagen
$46.26 /

-0.125 (-0.27%)

QGEN Qiagen
$46.26 /

-0.125 (-0.27%)

Earnings
AppLovin reports Q1 EPS (5c) vs. 1c last year » 16:17
05/12/21
05/12
16:17
05/12/21
16:17
APP

AppLovin

$52.11 /

-1.2 (-2.25%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APP AppLovin
$52.11 /

-1.2 (-2.25%)

05/10/21
Fly Intel: Top five analyst initiations
05/10/21 Stifel
AppLovin initiated with a Hold at Stifel
05/10/21 UBS
AppLovin initiated with a Buy at UBS
05/10/21 Truist
AppLovin initiated with a Buy at Truist
APP AppLovin
$52.11 /

-1.2 (-2.25%)

  • 15
    Apr
APP AppLovin
$52.11 /

-1.2 (-2.25%)

APP AppLovin
$52.11 /

-1.2 (-2.25%)

Earnings
cbdMD reports Q2 EPS (24c), consensus (3c) » 16:17
05/12/21
05/12
16:17
05/12/21
16:17
YCBD

cbdMD

$3.48 /

+0.05 (+1.46%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
YCBD cbdMD
$3.48 /

+0.05 (+1.46%)

YCBD cbdMD
$3.48 /

+0.05 (+1.46%)

YCBD cbdMD
$3.48 /

+0.05 (+1.46%)

YCBD cbdMD
$3.48 /

+0.05 (+1.46%)

Technical Analysis
NASDAQ market internals summary » 16:17
05/12/21
05/12
16:17
05/12/21
16:17
$NSD

NASDAQ Market Internals

/

+

Volume was above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Earnings
Exicure reports Q1 EPS (14c), consensus (12c) » 16:17
05/12/21
05/12
16:17
05/12/21
16:17
XCUR

Exicure

$1.68 /

-0.07 (-4.00%)

Reports Q1 revenue $997M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XCUR Exicure
$1.68 /

-0.07 (-4.00%)

XCUR Exicure
$1.68 /

-0.07 (-4.00%)

12/18/20 BMO Capital
Exicure initiated with an Outperform at BMO Capital
XCUR Exicure
$1.68 /

-0.07 (-4.00%)

Earnings
Acutus Medical sees FY21 revenue $22M-$30M , consensus $24.49M  16:17
05/12/21
05/12
16:17
05/12/21
16:17
AFIB

Acutus Medical

$11.64 /

-0.29 (-2.43%)

 
ShowHide Related Items >><<
AFIB Acutus Medical
$11.64 /

-0.29 (-2.43%)

AFIB Acutus Medical
$11.64 /

-0.29 (-2.43%)

03/19/21 Canaccord
Acutus Medical price target lowered to $16 from $30 at Canaccord
03/19/21 William Blair
Acutus Medical downgraded to Market Perform from Outperform at William Blair
03/19/21 JPMorgan
Acutus Medical downgraded to Neutral with $19 target at JPMorgan
03/19/21 JPMorgan
Acutus Medical downgraded to Neutral from Overweight at JPMorgan
AFIB Acutus Medical
$11.64 /

-0.29 (-2.43%)

  • 06
    Aug
AFIB Acutus Medical
$11.64 /

-0.29 (-2.43%)

AFIB Acutus Medical
$11.64 /

-0.29 (-2.43%)

Earnings
Coherent reports Q2 adjusted EPS $1.42, consensus $1.15 » 16:16
05/12/21
05/12
16:16
05/12/21
16:16
COHR

Coherent

$254.71 /

-5.125 (-1.97%)

Reports Q2 revenue $374M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COHR Coherent
$254.71 /

-5.125 (-1.97%)

COHR Coherent
$254.71 /

-5.125 (-1.97%)

05/07/21 Northland
II-VI upgraded to Outperform from Market Perform at Northland
03/26/21 Northland
NeoPhotonics deal 'makes more sense than ever' for Lumentum, says Northland
03/26/21 Cowen
II-VI weakness on deal announcement a buying opportunity, says Cowen
03/26/21 B. Riley Securities
II-VI upgraded to Buy from Neutral at B. Riley Securities
COHR Coherent
$254.71 /

-5.125 (-1.97%)

COHR Coherent
$254.71 /

-5.125 (-1.97%)

COHR Coherent
$254.71 /

-5.125 (-1.97%)

Hot Stocks
Alexion, Caelum announce CAEL-101 data presentations at EHA 2021 » 16:16
05/12/21
05/12
16:16
05/12/21
16:16
ALXN

Alexion

$172.10 /

+0.8 (+0.47%)

Caelum Biosciences and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALXN Alexion
$172.10 /

+0.8 (+0.47%)

ALXN Alexion
$172.10 /

+0.8 (+0.47%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
ALXN Alexion
$172.10 /

+0.8 (+0.47%)

ALXN Alexion
$172.10 /

+0.8 (+0.47%)

ALXN Alexion
$172.10 /

+0.8 (+0.47%)

Earnings
Spruce Biosciences reports Q1 EPS (42c), consensus (42c) » 16:16
05/12/21
05/12
16:16
05/12/21
16:16
SPRB

Spruce Biosciences

$14.80 /

+0.16 (+1.09%)

"Throughout the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPRB Spruce Biosciences
$14.80 /

+0.16 (+1.09%)

SPRB Spruce Biosciences
$14.80 /

+0.16 (+1.09%)

04/26/21 Credit Suisse
Spruce Biosciences assumed with an Outperform at Credit Suisse
11/03/20
Fly Intel: Top five analyst initiations
11/03/20 SVB Leerink
SVB Leerink bullish on Spruce Biosciences, initiates with an Outperform
11/03/20 SVB Leerink
Spruce Biosciences initiated with an Outperform at SVB Leerink
SPRB Spruce Biosciences
$14.80 /

+0.16 (+1.09%)

  • 09
    Oct
SPRB Spruce Biosciences
$14.80 /

+0.16 (+1.09%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.